ArticleCancer2022

Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies.

Antoine Hollebecque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.